Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study (vol 18, pg 3748, 2000)

Vergote, Ignace; Bonneterre, J; Thuerlimann, B

doi:10.1200/JCO.2011.41.3302

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study (vol 18, pg 3748, 2000)

Author:

Vergote, Ignace

Bonneterre, J ; Thuerlimann, B

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1103 Clinical Sciences, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3211 Oncology and carcinogenesis